Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta‐analysis

Published:2022-03-24 Issue:6 Volume:50 Page:300-312
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagnostic Cytopathology

Author:

Wang Jie¹,Zhao Xi²,Jiang Xiao Lei¹,Lu Dong¹,Yuan Qiang¹,Li Jiabing³^ORCID

Affiliation:

1. The Second Affiliated Hospital of North Sichuan Medical College Sichuan Mianyang 404 Hospital Mianyang China

2. Dalian Medical University Dalian Medical University Graduate School Dalian China

3. Mianyang Maternal and Child Health Hospital Sichuan Mianyang 404 Hospital Mianyang China

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dc.24954

Reference35 articles.

1. Mechanisms of immune evasion in bladder cancer

2. Cancer statistics in China, 2015

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

4. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

5. Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Point of Care Molecular Diagnostics in Cancer;Handbook of Oncobiology: From Basic to Clinical Sciences;2024

2. The Clinical Significance of Serum Free Light Chains in Bladder Cancer;Journal of Clinical Medicine;2023-05-05

3. Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis;Cancers;2023-01-24

4. Diagnostic Performances of Urine Cytology and TERT Promoter Mutations in Bladder Cancer;Journal of Population Therapeutics and Clinical Pharmacology;2023-01-01

5. Point of Care Molecular Diagnostics in Cancer;Handbook of Oncobiology: From Basic to Clinical Sciences;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3